newatlas.com / .newatlas-com-medical

Starting aerobic exercise just two months after a stroke is safe and may help protect thinking skills, according to new research. The study provides fresh hope for stroke survivors that they can reduce their elevated risk of dementia.

Got asthma? Then you might also go on to get Parkinson's. Celiac? You'll want to watch out for lung cancer. That's the kind of information you can get on a new website that uncovers the links between common conditions based on genetic analysis.

Noisy knees after an ACL injury may raise fears of impending arthritis, but new research shows that these noises signal existing damage and not future decline, helping patients and clinicians separate worry from real risk.

Heart failure with preserved ejection fraction (known as HFpEF), is the most common kind of heart failure, affecting millions globally. The heart still pumps, it just can't relax and fill appropriately. Think of it like a stiff balloon that won't ...

When parents sit too much, their kids tend to follow suit. But if parents keep active, children don't mirror the same sedentary habits, a new study has shown. It highlights the power of parents as role models for healthier lifestyles.

How and when we eat as we get older changes, but what impact this has on our health isn't well understood. New research, however, has found that in midlife and beyond, eating one particular meal later in the day is linked with a higher risk of early ...

Patients worldwide are cautiously optimistic about the use of AI in healthcare. Most support it as a helpful assistant, but few trust it to replace doctors, according to a new study that reveals trust, concerns, and the need for explainable AI.

A tiny implant that beams images straight to the retina, bypassing a damaged cornea altogether, could give sight back to millions living with corneal blindness - no donor tissue required. Human trials may be underway in as little as two years.

While artificial sweeteners were once touted as healthy alternatives to sugar, research continues to prove otherwise. Yet another study has now come along saying that six popular sweeteners might be truly terrible for our brains.

A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The treatment, called baxdrostat, has been hailed as the most promising advance in hypertension management in ...